The terms of the investment were not disclosed. In conjunction with the funding, Vanterra will join the BIOHM Health board along with the founders.
Led by CEO Afif Ghannoum, Biohm Health has applied proprietary dual-action technology that neutralizes the bad bacteria and fungi to provide the first probiotic to breakdown digestive plaque, while maintaining the balance of the gut’s total microbiome of bacteria and fungi. In addition to probiotics and other gut health products, the company offers The BIOHM Gut Report, which identifies and measures the gut’s important bacteria and fungi levels and provides individuals with actionable wellness recommendations, including nutritional advice based on personalized results.
The company was founded by Afif Ghannoum and Dr. Mahmoud Ghannoum after his discovery that bad bacteria and bad fungus work together to create digestive imbalance.